SS Innovations International Inc. (SSII) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 7 wire items for SSII, including 4 SEC filings, 2 press releases and news items and 1 insider trade. The most recent was published Oct 26, 2026.
Financial highlights
Full financials- Revenue, TTM
- $52.40M
- Revenue growth
- +89.7%
- Net income, TTM
- -$12.43M
- Net margin
- -23.7%
- Cash
- $13.65M
For the twelve months ended Jun 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks37-67%
2026-05-172026-11-08
Mix1590d
- SEC Filings9(60%)
- Other4(27%)
- Insider2(13%)
Activity · 52 weeks9152 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 8-K filed by SS Innovations International Inc.8-K - SS Innovations International, Inc. (0001676163) (Filer)
- PRSS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 ConferencesFORT LAUDERDALE, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s SSi Mantra surgical robotic system (the "SSi Mantra") and SSi MantrAsana tele-surgeon console (the "SSi MantrAsana") were showcased in successful telesurgeries performed in October 2026 during the European Association for Cardio-Thoracic Surgery ("EACTS") Annual Meeting in Barcelona, Spain and the Society of Robotic Surgery India ("SRS India") Conference in New Delh
- SECSEC Form 8-K filed by SS Innovations International Inc.8-K - SS Innovations International, Inc. (0001676163) (Filer)
- PRSS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi MantraFORT LAUDERDALE, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that, on October 5, 2026, the Company submitted its response to a request for additional information letter (the "AINN") received from the United States Food and Drug Administration (the "FDA") with regard to the Company’s 510(k) submission for its SSi Mantra surgical robotic system (the "SSi Mantra"). The Company’s response to the AINN includes final data from an expanded human cl
- SECSEC Form 8-K filed by SS Innovations International Inc.8-K - SS Innovations International, Inc. (0001676163) (Filer)
- INSIDERSEC Form 4 filed by SS Innovations International Inc.4 - SS Innovations International, Inc. (0001676163) (Issuer)
- SECSEC Form 424B5 filed by SS Innovations International Inc.424B5 - SS Innovations International, Inc. (0001676163) (Filer)
- SECSS Innovations International Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - SS Innovations International, Inc. (0001676163) (Filer)
- SECSS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - SS Innovations International, Inc. (0001676163) (Filer)
- PRSS Innovations Provides Update on Continuing Progress and Milestones-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided an update on the Company’s continuing progress and milestones. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, "Our advanced, cost-effective SSi Mantra surgical robotic system (the "SSi
- INSIDERChairman and CEO Sudhir Srivastava sold $99,999 worth of shares (33,333 units at $3.00) (SEC Form 4)4 - SS Innovations International, Inc. (0001676163) (Issuer)
- SECSS Innovations International Inc. filed SEC Form 8-K: Leadership Update8-K - SS Innovations International, Inc. (0001676163) (Filer)
- SECSS Innovations International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - SS Innovations International, Inc. (0001676163) (Filer)
- PRSS Innovations Reports Second Quarter 2026 Financial ResultsFORT LAUDERDALE, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and six months ended June 30, 2026. The Company also filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, with the Securities and Exchange Commission on August 13, 2026. Second Quarter 2026 Overview Revenue increased 39.4% to $13.9 million from $10.0 million in the second quarter of 2025.Gross margin equaled 50.9%, c
- SECSEC Form 10-Q filed by SS Innovations International Inc.10-Q - SS Innovations International, Inc. (0001676163) (Filer)
- INSIDERSEC Form 3 filed by new insider Romano Sarah3 - SS Innovations International, Inc. (0001676163) (Issuer)
- SECSS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - SS Innovations International, Inc. (0001676163) (Filer)
- PRSS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026FORT LAUDERDALE, Fla., July 17, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the advanced SSi Mantra surgical robotic system (the "SSi Mantra") will be showcased at the 2026 Society of Robotic Surgery Annual Meeting ("SRS 2026") in Hollywood, Florida, on July 23 - 26, 2026. The SSi Mantra will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the event. The livestreamed robotic telesur
- SECSS Innovations International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - SS Innovations International, Inc. (0001676163) (Filer)
- PRSS Innovations Appoints Sarah M. Romano as Chief Financial OfficerFORT LAUDERDALE, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. Ms. Romano will be based in the United States. Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, "We are thrilled to welcome Sarah as our Chief Financial Officer at this critical moment in our growth journey. As we continue our global expansio
- SECSS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - SS Innovations International, Inc. (0001676163) (Filer)
- PRSS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training ClassFORT LAUDERDALE, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s subsidiary, the SS International Centre for Robotics Surgery ("SSICRS"), has graduated its first class in a specialized training course designed to provide surgeons and other healthcare professionals with classroom instruction and hands-on learning in robotic-assisted cardiac surgery using the advanced SSi Mantra surgical robotic system (the "SSi Mantra") at SSICRS’
- PRIBN Initiates Coverage of SS Innovations International, Inc.AUSTIN, Texas, July 07, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy. SS Innovations’ technology portfolio is anchored by the proprietary SSi Mantra surgical robotic system, a modular platform designed to support a broad range of minimally invasive procedures across multiple surgical specialties. The system features three to five robotic arms, a 3D 4K v
- PRSS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry AwardsFORT LAUDERDALE, Fla., June 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company was named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards ("SRIA"). Each year, in the Outstanding Company category, SRIA recognizes a single winning surgical robotics company that demonstrates one or more of the following characteristics: an outstanding business or commercial success;a highly novel and/or inventive produ
- SECSS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - SS Innovations International, Inc. (0001676163) (Filer)
SSII FAQ
8 questionsWhat is the latest news on SSII?
In the last 30 days Quantisnow tracked 7 wire items for SSII: 4 SEC filings, 2 press releases and news items and 1 insider trade. The most recent was published on October 26, 2026.What is SSII revenue?
SS Innovations International Inc. (SSII) reported $52.40M of revenue for the twelve months ended Jun 30, 2026. That is up 89.7% from the year before. Revenue for fiscal 2025 was $42.48M.Is SSII profitable?
No. SS Innovations International Inc. reported a net loss of $12.43M for the twelve months ended Jun 30, 2026.How much cash and debt does SSII have?
SS Innovations International Inc. reported $13.65M in cash and cash equivalents and $240.5K of debt on its most recent balance sheet in SEC filings.Where does SSII stock trade?
SS Innovations International Inc. (SSII) is listed on NASDAQ.What sector and industry is SSII in?
SS Innovations International Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What companies are similar to SSII?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare SSII side-by-side with any of them on Quantisnow.How can I track SSII on Quantisnow?
Quantisnow aggregates SS Innovations International Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SSII to receive live email and push alerts on every new disclosure.